Shares of Dermata Therapeutics, Inc. (NASDAQ: DRMA) rose sharply in pre-market trading after the company announced the issuance of a new patent in Japan for its DMT410 program for the treatment of hyperhidrosis.
Dermata Therapeutics shares jumped 57.3% to $0.9601 in pre-market trading.
Shares of ReShape Lifesciences Inc. (NASDAQ: RSLS) rose sharply in pre-market trading after the company said it received FDA PMA supplement approval for its next-generation Lap-Band 2.0 FLEX.
ReShape Lifesciences shares jumped 44.6% to $0.3630 in pre-market trading.
The Pension Benefit Guaranty Corporation (PBGC), a federal agency tasked with protecting the retirement security of more than 33 million Americans in single-employer and multiemployer pension plans, has renewed its PBGC